Now showing items 1-2 of 2

    • Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents 

      Sanz-Nogués, Clara; O'Brien, Timothy (Elsevier, 2021-05-05)
      Producing human mesenchymal stromal cells (MSCs) for clinical use requires adherence to current good manufacturing practice (cGMP) standards. This is necessary for ensuring standardization and reproducibility through the ...
    • Future directions in managing aniridia-associated keratopathy 

      van Velthoven, Arianne J.H.; Utheim, Tor P.; Notara, Maria; Bremond-Gignac, Dominique; Figueiredo, Francisco C.; Skottman, Heli; Aberdam, Daniel; Daniels, Julie T.; Ferrari, Giulio; Grupcheva, Christina; Koppen, Carina; Parekh, Mohit; Ritter, Thomas; Romano, Vito; Ferrari, Stefano; Cursiefen, Claus; Lagali, Neil; LaPointe, Vanessa L.S.; Dickman, Mor M. (Elsevier, 2023-05-04)
      Congenital aniridia is a panocular disorder that is typically characterized by iris hypoplasia and aniridia-associated keratopathy (AAK). AAK results in the progressive loss of corneal transparency and thereby loss of ...